The 11th Global Drug Delivery & Formulation (DDF) Summit will bring together the pharmaceutical development community in Berlin, Germany. At this high-level scientific summit scientists and technologists representing big pharma, subject matter experts, solution providers and academia will meet and discuss exciting future innovations. Lonza scientists will be present and look forward to discussing how we can assist in advancing your promising molecules.
For registration click here.
Join David Lyon, PhD, Sr. Fellow - Research at Lonza Pharma & Biotech
on Monday, 9 March 2020 at 2:30 pm
and learn more about
"An Integrated Approach to Rapidly Advancing Poorly Bioavailable Compounds to the Clinic”.
- Integration of active pharmaceutical ingredient synthesis and drug product development activities
- Technology selection for poorly soluble molecules based on physical-chemical properties
- Tools and approaches for the rapid advancement of poorly soluble compounds to the clinic
- Representative case studies
Currently it is estimated that over 70% of the compounds in development have dissolution rate and/or solubility issues that require enabling technologies to achieve adequate oral absorption. Furthermore, a significant fraction of these assets is held by small-to-medium sized biotechnology companies that often lack resources and “bricks and mortar” to independently drive the compounds to the clinic and beyond.
In this talk we will discuss an integrated service offering specifically developed to rapidly advance poorly soluble assets to the clinic. This flexible service offering utilizes in silico predictions and bulk sparing laboratory tests to develop clinically ready formulations with a line of sight to commercial production
Can't attend the show? Join our next webinar register here
27 February 2020 • 8 a.m. PST / 11 a.m. EST
Learn more about our SimpliFiH Solutions™ integrated first-in-human service offering click here.
Use the form below to schedule a meeting with Lonza team